's Top Upgrades

Home › 's Top Upgrades

Analysts at Goldman Sachs upgraded Myriad Genetics, Inc. from Sell to Neutral. The price target for Myriad Genetics has been raised from $31 to $40.

22.11	Trump expected to tab Kelly Loeffler for Secretary of Agriculture
22.11	Hay supply is likely up, but winter feed costs still matter
22.11	Future plans for US SHIP and USDA's role explored
22.11	Strategy for increasing feed efficiency for cows
22.11	Top 3 myths of cattle marketing
22.11	Carcass management workshop gets pork producers FAD prepared
22.11	Are we close to eliminating Mycoplasma hyopneumoniae from the U.S. swine herd?
22.11	Costa to challenge Scott for top House Agriculture Democrat role
Agriculture and Forestry »

je.st